Immunovant (IMVT) Interest Coverage Ratio (2019)

Immunovant (IMVT) reported Interest Coverage Ratio of 28.78 for Q4 2019, down 1607.03% quarter-over-quarter from 1.69 in Q3 2019.

Immunovant (IMVT) Interest Coverage Ratio (2019) Analysis & Trends

Immunovant has reported Interest Coverage Ratio for 1 years, with the latest figure at 28.78 in Q4 2019.

For the quarter ending Q4 2019, Interest Coverage Ratio changed N/A year-over-year to 28.78; the trailing twelve-month figure through Sep 2020 stood at 209.68 (down 184.09% YoY), and the FY2020 full-year result was 105.07, changed N/A from the prior year.
Interest Coverage Ratio for Q4 2019 stood at 28.78, down from 1.69 in the prior quarter.
The five-year high for Interest Coverage Ratio was 1.69 in Q3 2019, with the low at 28.78 in Q4 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	3.58
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-258.33
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	11.50
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	547.67
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-
9	Abivax	91.71 Bn	91.71 Bn	-	11.79
10	Immunovant	5.71 Bn	5.71 Bn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2019	-28.78
Sep 30, 2019	-1.69